Cargando…
A systems immunology study comparing innate and adaptive immune responses in adults to COVID-19 mRNA and adenovirus vectored vaccines
Identifying the molecular mechanisms that promote optimal immune responses to coronavirus disease 2019 (COVID-19) vaccination is critical for future rational vaccine design. Here, we longitudinally profile innate and adaptive immune responses in 102 adults after the first, second, and third doses of...
Autores principales: | Ryan, Feargal J., Norton, Todd S., McCafferty, Conor, Blake, Stephen J., Stevens, Natalie E., James, Jane, Eden, Georgina L., Tee, Yee C., Benson, Saoirse C., Masavuli, Makutiro G., Yeow, Arthur E.L., Abayasingam, Arunasingam, Agapiou, David, Stevens, Hannah, Zecha, Jana, Messina, Nicole L., Curtis, Nigel, Ignjatovic, Vera, Monagle, Paul, Tran, Huyen, McFadyen, James D., Bull, Rowena A., Grubor-Bauk, Branka, Lynn, Miriam A., Botten, Rochelle, Barry, Simone E., Lynn, David J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9935276/ https://www.ncbi.nlm.nih.gov/pubmed/36871558 http://dx.doi.org/10.1016/j.xcrm.2023.100971 |
Ejemplares similares
-
Preclinical Development and Production of Virus-Like Particles As Vaccine Candidates for Hepatitis C
por: Masavuli, Makutiro Ghislain, et al.
Publicado: (2017) -
A Hepatitis C Virus DNA Vaccine Encoding a Secreted, Oligomerized Form of Envelope Proteins Is Highly Immunogenic and Elicits Neutralizing Antibodies in Vaccinated Mice
por: Masavuli, Makutiro Ghislain, et al.
Publicado: (2019) -
Cytolytic Perforin as an Adjuvant to Enhance the Immunogenicity of DNA Vaccines
por: Shrestha, Ashish C., et al.
Publicado: (2019) -
Toward DNA-Based T-Cell Mediated Vaccines to Target HIV-1 and Hepatitis C Virus: Approaches to Elicit Localized Immunity for Protection
por: Mekonnen, Zelalem A., et al.
Publicado: (2019) -
SARS-CoV-2 Omicron variant escapes neutralizing antibodies and T cell responses more efficiently than other variants in mild COVID-19 convalescents
por: Garcia-Valtanen, Pablo, et al.
Publicado: (2022)